- Chart
- Upturn Summary
- Highlights
- Valuation
- About
OneMedNet Corp. (ONMDW)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/11/2025: ONMDW (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit -47.77% | Avg. Invested days 21 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.76 | 52 Weeks Range 0.01 - 0.08 | Updated Date 05/26/2025 |
52 Weeks Range 0.01 - 0.08 | Updated Date 05/26/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -1623.36% |
Management Effectiveness
Return on Assets (TTM) -489.93% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 15312402 |
Shares Outstanding - | Shares Floating 15312402 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
OneMedNet Corp.
Company Overview
History and Background
OneMedNet Corp. is a digital health company focused on accelerating medical research and improving patient care through innovative data solutions. The company was founded with the goal of democratizing access to medical imaging data for research purposes. Significant milestones include the development of their proprietary platform and strategic partnerships with healthcare providers and research institutions. Their evolution has been driven by the increasing demand for real-world evidence and the advancements in AI and machine learning within healthcare.
Core Business Areas
- AI-Powered Medical Imaging Solutions: OneMedNet offers a platform that facilitates the secure sharing and analysis of de-identified medical imaging data for research. This includes tools for data curation, annotation, and AI model development, enabling researchers to train and validate algorithms more efficiently.
- Real-World Evidence (RWE) Generation: The company supports the generation of real-world evidence by providing access to diverse and de-identified patient datasets. This RWE is crucial for understanding treatment effectiveness, disease progression, and comparative analyses in various clinical settings.
- Clinical Trial Support: OneMedNet assists in optimizing clinical trials by providing access to relevant patient cohorts and facilitating data-driven insights for trial design and patient recruitment.
Leadership and Structure
Information on OneMedNet Corp.'s specific leadership team and organizational structure is best obtained from their official investor relations or company website, as this can change frequently. Generally, they operate with a structure typical of technology and healthcare companies, including departments for research and development, sales and marketing, operations, and data science.
Top Products and Market Share
Key Offerings
- Product Name 1: OneMedNet's proprietary data platform is their core offering. It enables researchers to access, analyze, and annotate de-identified medical imaging datasets. The platform's market share is difficult to quantify directly as it operates within a niche market of data providers for medical research. Key competitors in providing such platforms include companies focused on AI in radiology and data aggregation for research. Specific revenue figures for this product are not publicly disclosed.
Market Dynamics
Industry Overview
The digital health industry, particularly the segment focused on medical imaging data and AI for research, is experiencing rapid growth. Driven by the increasing volume of medical imaging data, the need for advanced diagnostic tools, and the pursuit of personalized medicine, this sector is characterized by innovation and significant investment. The growing emphasis on real-world evidence in drug development and regulatory submissions further fuels this growth.
Positioning
OneMedNet is positioned as a facilitator of medical research and AI development by providing access to de-identified medical imaging data. Their competitive advantage lies in their specialized platform designed for this purpose, aiming to streamline the research process and accelerate the deployment of AI solutions in healthcare. They aim to be a key enabler for both academic and commercial researchers.
Total Addressable Market (TAM)
The Total Addressable Market for medical imaging data analytics and AI in healthcare research is substantial and growing, estimated to be in the tens of billions of dollars globally and projected to expand significantly in the coming years. OneMedNet is positioned to capture a segment of this TAM by focusing on data access and AI model development for research purposes. Their success will depend on their ability to secure a broad base of data sources and attract a significant number of research users.
Upturn SWOT Analysis
Strengths
- Proprietary data platform designed for medical imaging research.
- Focus on de-identified data for research, addressing privacy concerns.
- Potential to accelerate AI development in radiology and other imaging specialties.
- Partnerships with healthcare providers for data access.
Weaknesses
- Relatively young company with limited brand recognition compared to established players.
- Dependence on data partnerships, which can be complex to establish and maintain.
- Need for continuous investment in technology and R&D.
- Challenges in demonstrating direct, quantifiable ROI to all potential clients.
Opportunities
- Growing demand for AI-powered medical diagnostics.
- Increasing use of Real-World Evidence (RWE) in drug development and healthcare policy.
- Expansion into new therapeutic areas and imaging modalities.
- Strategic acquisitions or partnerships to broaden data access or technological capabilities.
Threats
- Increasing competition from established tech companies and other startups in the health AI space.
- Evolving data privacy regulations and compliance challenges.
- Potential for data security breaches, although mitigated by de-identification.
- Difficulty in achieving widespread adoption and integration into existing research workflows.
Competitors and Market Share
Key Competitors
- Nvidia Corp. (NVDA)
- Google (GOOGL/GOOG)
- Microsoft Corp. (MSFT)
- GE Healthcare (GEHC)
- Philips (PHG)
Competitive Landscape
OneMedNet operates in a highly competitive landscape dominated by larger tech companies and established healthcare equipment providers who are also investing heavily in AI and data solutions. OneMedNet's advantage lies in its specialized focus on medical imaging data access for research, whereas larger competitors may offer broader AI platforms or hardware. Its agility and niche expertise can be a strength, but it faces challenges in competing with the resources and market reach of its larger rivals.
Major Acquisitions
N/A
- Year:
- Acquisition Price (USD millions):
- Strategic Rationale: No significant publicly disclosed acquisitions by OneMedNet Corp. at this time.
Growth Trajectory and Initiatives
Historical Growth: OneMedNet's historical growth has likely been characterized by the expansion of its platform capabilities, the addition of new data partners, and the growing adoption of its solutions by the research community. Initial growth phases often involve significant investment in R&D and market development.
Future Projections: Future growth projections for OneMedNet are typically driven by analysts' expectations based on market trends, company strategy, and its ability to scale its operations and customer base. Key drivers for future growth include the increasing demand for AI in healthcare, the expanding RWE market, and the development of new product features.
Recent Initiatives: Recent initiatives by OneMedNet Corp. may include expanding their network of healthcare data partners, enhancing their AI tools and analytics capabilities, forming strategic alliances for specific research projects or therapeutic areas, and pursuing new market segments for their data solutions.
Summary
OneMedNet Corp. is a promising player in the growing field of AI-driven medical imaging research. Its specialized platform for de-identified data access is a key strength, positioning it to capitalize on the increasing demand for real-world evidence and AI in healthcare. However, the company faces significant competition from larger, well-funded entities and must continuously innovate and secure data partnerships to maintain its growth trajectory. Careful management of resources and strategic market positioning will be crucial for its long-term success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Investor Relations Filings (SEC Edgar Database)
- Reputable Financial News Outlets (e.g., Wall Street Journal, Bloomberg)
- Industry Analysis Reports
- Company Official Website
Disclaimers:
This JSON output is for informational purposes only and should not be considered financial advice. Data accuracy is dependent on the timeliness and completeness of publicly available information. Market share and financial data may be estimates or subject to change. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OneMedNet Corp.
Exchange NASDAQ | Headquaters Eden Prairie, MN, United States | ||
IPO Launch date 2021-06-24 | CEO, President & Director Mr. Aaron Green | ||
Sector Healthcare | Industry Health Information Services | Full time employees 22 | Website https://www.onemednet.com |
Full time employees 22 | Website https://www.onemednet.com | ||
OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. The company offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets; and BEAM, a medical imaging exchange platform between hospital/healthcare systems, imaging centers, physicians, and patients. OneMedNet Corporation is headquartered in Eden Prairie, Minnesota.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

